|
FY2024
12 months to Feb 29, 2024
|
FY2023
12 months to Feb 28, 2023
|
FY2022
12 months to Feb 28, 2022
|
FY2021
12 months to Feb 28, 2021
|
|
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue, excluding depreciation and amortization | ||||
| Operating expenses: | ||||
| Product and technology | ||||
| Sales and marketing | ||||
| General and administrative | ||||
| Depreciation and amortization | ||||
| Goodwill impairment | ||||
| Change in fair value of contingent consideration | ||||
| Total operating expenses | ||||
| Loss from operations | ||||
| Interest income (expense), net | ||||
| Other income (expense) | ||||
| Loss before income taxes | ||||
| Income tax benefit (expense) | ||||
| Net loss | ||||
| Net loss per share, basic (USD per share) | ||||
| Net loss per share, diluted (USD per share) | ||||
| Weighted-average common shares outstanding - basic (in shares) | ||||
| Weighted-average common shares outstanding - diluted (in shares) | ||||
| Other comprehensive loss: | ||||
| Unrealized loss on marketable securities, net | ||||
| Comprehensive loss | ||||
Loading...
